We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-8 of 8

China’s Patent Re-Examination Board says pharmaceutical salts not patentable over pure compounds

  • Greenberg Traurig LLP
  • -
  • China
  • -
  • August 14 2013

In July 2013, the Patent Re-Examination Board of China's State Intellectual Property Office invalidated the U.S. biotech company, Gilead Sciences'

China newsletter - summer 2013

  • Greenberg Traurig LLP
  • -
  • China, Macau
  • -
  • July 17 2013

For the purpose of fully implementing the spirit of the Eighteenth National Congress of the Communist Party of China and attracting more foreign

Life sciences: 2013 legal developments you need to know about

  • Mayer Brown LLP
  • -
  • China, European Union, France, USA
  • -
  • July 16 2013

This is a short guide outlining some of the key legal developments in the life sciences sector in 2013. The developments include the Supreme Court

Changing trends in patent protection for the pharma industry

  • Heskia - Hacmun Law Firm
  • -
  • China, India, Israel
  • -
  • June 6 2013

This April India's Supreme Court oversaw a high profile case involving Novartis' patent application for Glivec, a cancer-battling medication

Insights on drafting pharmaceutical patents from the “Supreme People’s Court’s Annual Report of Intellectual Property Cases”

  • King & Wood Mallesons
  • -
  • China
  • -
  • May 31 2013

In April 2013, the Supreme People's Court ("SPC") issued the"Supreme People's Court's Annual Report of Intellectual Property Cases", in which the SPC

Overview of patent-statutory subject matter in biotechnology

  • CCPIT Patent & Trademark Law Office
  • -
  • China, European Union, Japan, USA
  • -
  • April 8 2013

With the advent of biotechnology, the human community stands on the threshold of an extraordinary revolution having profound

The Patent Reexamination Board makes a clear explanation about whether the invention relating to embryonic stem cells is contrary to the social morality or not

  • Wan Hui Da Intellectual Property Agency
  • -
  • China
  • -
  • March 29 2013

Reexamination Board (PRB) on this case provides the guidance for the judgment on whether the invention relating to embryonic stem cells is contrary

Life sciences health industry China briefing - November 2011

  • Reed Smith LLP
  • -
  • China
  • -
  • December 6 2011

The Beijing Health Bureau announced November 9 that the hospital grading appraisal will be initiated in 2012